Siliq Injection
Product Images NDC 0187-0004

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Siliq (NDC 0187-0004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Siliq (brodalumab) Injection 210 mg/1.5 mL Label (Carton)

Carton packaging label for Siliq (brodalumab) injection, 210 mg/1.5 mL, subcutaneous injection by Bausch Health US LLC. The carton contains 2 single-dose prefilled syringes. The label highlights storage instructions, contents, NDC 0187-0004-02, and specifies prescription use only.*

FDA Label Image

Singledose Pfs (Image 01)

An instructional illustration showing a prefilled syringe labeled with product details and expiration date. The syringe is shown before use with the plunger rod extended and needle capped in gray, and after use with the plunger rod fully depressed, needle exposed, and needle cap removed. Finger flanges are visible on both states.*

FDA Label Image

Step 1-a (Image 02)

An instructional illustration showing a hand reaching into a box containing multiple prefilled syringes arranged in a row. The image likely demonstrates how to select or handle an injection device, relevant for subcutaneous administration of medication such as Siliq (Brodalumab) injection.*

FDA Label Image

Step 1-a (Image 03)

Instructional illustration showing hands holding a medication injection device inside a box, with arrows indicating where to grab or pull the device. The text 'Grab Here' is visible below the image, suggesting guidance for handling or preparing the subcutaneous injection.*

FDA Label Image

Step 1-b (Image 04)

An instructional diagram illustrating the parts of a Siliq (Brodalumab) 210 mg/1 subcutaneous injection syringe. Labeled components include the gray needle cap on, syringe barrel containing medicine, label and expiration date on the barrel, plunger rod, and finger flange for grip during injection.*

FDA Label Image

Step 1-c (Image 05)

Illustration showing a medical syringe with a needle on the left and various medication disposal items on the right, including a biohazard sharps container, medication blister pack, tablets, and a paper insert, likely representing components related to subcutaneous injection use and disposal.*

FDA Label Image

Step 1-d (Image 06)

An instructional illustration showing recommended subcutaneous injection sites on the human body. Highlighted areas include the upper arm, stomach area (abdomen), and thigh, indicating where the injection can be administered.*

FDA Label Image

Step 2-e (Image 07)

An instructional illustration showing a hand pulling an item upwards from a syringe held by another hand. The syringe appears to be ready for injection with the plunger and needle visible. This image likely demonstrates a step in preparing or using an injection device.*

FDA Label Image

Step 2-f (Image 08)

An instructional illustration showing a person using two fingers to pinch a fold of skin on the abdomen. Arrows indicate the upward motion of the fingers, demonstrating proper technique for preparing a subcutaneous injection.*

FDA Label Image

Step 3-g (Image 09)

An instructional illustration showing the proper angle for a subcutaneous injection, with a hand holding a syringe. The image indicates two angle options, 90 degrees and 45 degrees, to be used for injecting beneath the skin.*

FDA Label Image

Step 3-h (Image 10)

An instructional diagram showing the administration of a subcutaneous injection using a syringe, with one hand holding the syringe and the other pinching the skin at the injection site.*

FDA Label Image

Step 3-i (Image 11)

An instructional illustration showing the subcutaneous injection process using a syringe. The image depicts hands administering an injection into the skin, with an arrow indicating the upward motion of pulling the syringe out post-injection. It appears to guide users on proper syringe removal after injecting.*

FDA Label Image

Step 4-k (Image 12)

An instructional illustration showing a hand holding a syringe with a needle, positioned to be inserted into a biohazard sharps disposal container. An arrow indicates the syringe should be inserted downward into the container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.